Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs AlyveRx

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, AlyveRx a 74. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

AlyveRx

#143 · Grade C+ · Watch List

Est. first month

From $183/mo (all doses, compounded)

Save ~86% vs brand-name
Get this deal Full AlyveRx review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 74 an est. $99/mo first month, with no teaser step-up baked in. AlyveRx isn't out of it: People who want needle-free sublingual GLP-1 options alongside standard compounded injections.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDAlyveRx
Value Score89 (A)74 (C+)
Est. first month$99/moFrom $183/mo (all doses, compounded)
Save vs brand-name~93%~86%
Semaglutide$99/moFrom $183/mo (all doses, compounded)
Tirzepatide$139/moFrom $249/mo (all doses, compounded)
Both moleculesYesYes
PricingFlat — no step-upFlat — no step-up
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
75
bmiMD: 95. AlyveRx: 75.
84
No Teaser-Rate Bait
90
bmiMD: 84. AlyveRx: 90.
98
Nationwide Availability
45
bmiMD: 98. AlyveRx: 45.
94
Both Molecules
98
bmiMD: 94. AlyveRx: 98.
82
Easy Cancellation
58
bmiMD: 82. AlyveRx: 58.
70
Reputation
60
bmiMD: 70. AlyveRx: 60.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

AlyveRx

AlyveRx (Alyve, Inc.) is a US online telehealth platform connecting patients with licensed providers for GLP-1 weight loss care, no insurance required, with free discreet delivery.

Why it's a deal

  • Offers compounded semaglutide and tirzepatide as both injections and needle-free sublingual drops for people who dislike needles
  • Transparent monthly pricing shown upfront, no insurance required, and free discreet delivery
  • Also carries brand-name Ozempic, Wegovy, and Mounjaro through its provider network

The fine print

  • Does not publicly name its dispensing pharmacy or display a LegitScript seal, so third-party accreditation is unverified
  • Sublingual GLP-1 absorption relies on the company proprietary PermeAct technology and is not FDA-reviewed for weight loss
  • State availability is not published on the site
Get the bmiMD deal Get the AlyveRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to AlyveRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.